newsfilter
← Latest News
PR Newswire·

Portola Pharmaceuticals Announces Proposed Offering of Common Stock

Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced plans to offer, subject to market and other conditions, $200 million of its common...